Simplex Trading’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$451K Buy
49,400
+32,400
+191% +$272K ﹤0.01% 3388
2025
Q4
$126K Buy
17,000
+8,900
+110% +$64K ﹤0.01% 4733
2025
Q3
$54K Buy
+8,100
New +$56.2K ﹤0.01% 6369
2025
Q2
Sell
-10,900
Closed -$99K 8683
2025
Q1
$99K Buy
10,900
+5,600
+106% +$55.9K ﹤0.01% 5065
2024
Q4
$55K Sell
5,300
-8,500
-62% -$101K ﹤0.01% 5772
2024
Q3
$164K Sell
13,800
-1,100
-7% -$9.51K ﹤0.01% 4712
2024
Q2
$85K Sell
14,900
-6,500
-30% -$35.7K ﹤0.01% 5531
2024
Q1
$111K Buy
21,400
+12,200
+133% +$59.6K ﹤0.01% 5473
2023
Q4
$48K Buy
9,200
+2,900
+46% +$11.5K ﹤0.01% 6113
2023
Q3
$20K Sell
6,300
-64,400
-91% -$226K ﹤0.01% 6609
2023
Q2
$204K Buy
70,700
+63,500
+882% +$122K ﹤0.01% 4271
2023
Q1
$7K Buy
+7,200
New +$13.8K ﹤0.01% 7795
2022
Q2
Sell
-200
Closed -$2K 10000
2022
Q1
$2K Sell
200
-6,300
-97% -$84.3K ﹤0.01% 9824
2021
Q4
$94K Buy
+6,500
New +$92.4K ﹤0.01% 6352

Other funds holding BVS

Simplex Trading's BVS Position: Q1 2025 in Review

Simplex Trading sold out of Bioventus (BVS) in Q1 2025, closing a stake of 21,180 shares — an estimated $212K sold.

Simplex Trading first reported a position in BVS in Q1 2022 and held it in 11 quarters. The position peaked at $222K in Q4 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Simplex Trading reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 21,180 Bioventus shares in Q1 2025, an estimated $212K.
  • Simplex Trading first reported a position in Bioventus in Q1 2022 and held it in 11 quarters.
  • Simplex Trading's Bioventus position peaked at $222K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.